Please login to the form below

Not currently logged in
Email:
Password:

dacomitinib

This page shows the latest dacomitinib news and features for those working in and with pharma, biotech and healthcare.

Reviews start for Pfizer’s wildcard lung cancer drug dacomitinib

Reviews start for Pfizer’s wildcard lung cancer drug dacomitinib

Reviews start for Pfizer’ s wildcard lung cancer drug dacomitinib. Both EU and US regulatory advisors are currently assessing the drug. ... Regulatory reviews have started for Pfizer’s non-small cell lung cancer drug dacomitinib on both sides of the

Latest news

More from news
Approximately 2 fully matching, plus 9 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Wordbird

Wordbird is a healthcare communications agency with creative, compelling copy at its heart....

Latest intelligence

No incentive for a cure
The paradox of ‘cost-effective but unaffordable’ life-saving medicines...
Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...

Infographics